DALIRESP® (roflumilast) tablets

DALIRESP® (roflumilast) tablets

DALIRESP is a selective phosphodiesterase 4 inhibitor indicated as a treatment to reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.